New drug shows promise for rare bone cancer patients
NCT ID NCT04278781
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 24 times
Summary
This study tests whether the drug AG-120 can safely control tumor growth in people with advanced or recurrent chondrosarcoma, a rare bone cancer, that has a specific IDH1 gene mutation. Six adults with grade 2 or 3 disease are enrolled. The main goal is to see how long the cancer stays stable or shrinks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHONDROSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University (Specimen Analysis Only)
New York, New York, 10032, United States
-
Johns Hopkins Hospital (Data Collection Only)
Baltimore, Maryland, 21287, United States
-
MD Anderson Cancer Center (Data Collection Only)
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
The Ohio State University (Data Collection Only)
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.